Binding ligand linked drug delivery conjugates of tubulysins
    11.
    发明申请
    Binding ligand linked drug delivery conjugates of tubulysins 审中-公开
    肾上腺素的结合配体连接的药物递送共轭物

    公开(公告)号:US20130116195A1

    公开(公告)日:2013-05-09

    申请号:US13507076

    申请日:2012-06-01

    IPC分类号: A61K38/08

    摘要: Described herein are compounds, pharmaceutical compositions, and methods for treating pathogenic cell populations. Kits including the compounds or pharmaceutical compositions are described. The compounds described herein include conjugates of tubulysins and folates. The conjugates also include a releasable bivalent linker.

    摘要翻译: 本文描述了用于治疗致病细胞群体的化合物,药物组合物和方法。 描述了包括化合物或药物组合物的试剂盒。 本文所述的化合物包括肾上腺素和叶酸盐的缀合物。 缀合物还包括可释放的二价连接体。

    Methods and compositions for treating and diagnosing kidney disease
    18.
    发明授权
    Methods and compositions for treating and diagnosing kidney disease 有权
    治疗和诊断肾脏疾病的方法和组合物

    公开(公告)号:US08765096B2

    公开(公告)日:2014-07-01

    申请号:US13440641

    申请日:2012-04-05

    IPC分类号: A61K51/00 A61M36/14 A61K51/04

    摘要: The invention relates to a method for diagnosing a kidney disease state. The method comprises the steps of administering to a patient a composition comprising a conjugate or complex of the general formula V-L-D where the group V comprises a vitamin receptor binding ligand that binds to kidney proximal tubule cells and the group D comprises a diagnostic marker, and diagnosing the kidney disease state. The invention also relates to a method for treating a kidney disease state. The method comprises the steps of administering to a patient suffering from the disease state an effective amount of a composition comprising a conjugate or complex of the general formula V-L-D where the group V comprises a vitamin receptor binding ligand that binds to kidney proximal tubule cells and the group D comprises an antigen, a cytotoxin, or a cell growth inhibitor, and eliminating the disease state.

    摘要翻译: 本发明涉及诊断肾脏疾病状态的方法。 该方法包括以下步骤:向患者施用包含通式VLD的缀合物或复合物的组合物,其中组V包含结合肾近端小管细胞的维生素受体结合配体,D组包括诊断标记物,并诊断 肾脏疾病状态。 本发明还涉及治疗肾脏疾病状态的方法。 该方法包括以下步骤:向患有疾病状态的患者施用有效量的包含通式VLD的缀合物或复合物的组合物,其中组V包含结合肾近端小管细胞的维生素受体结合配体, D组包含抗原,细胞毒素或细胞生长抑制剂,并消除疾病状态。

    Multi-drug ligand conjugates
    19.
    发明授权
    Multi-drug ligand conjugates 失效
    多药物配体缀合物

    公开(公告)号:US08465724B2

    公开(公告)日:2013-06-18

    申请号:US12064191

    申请日:2006-08-18

    IPC分类号: A61K51/00 A61M36/14

    摘要: Described herein are compounds, pharmaceutical compositions and methods for treating pathogenic cell populations in a patient. The compounds described herein include conjugates of a plurality of cytotoxic drugs and vitamin receptor binding ligands. The plurality of drugs may be the same or different. Similarly, the vitamin receptor binding ligands may be the same or different. The conjugates also include a linker that is formed from one or more spacer linkers, heteroatom linkers, and releasable linkers.

    摘要翻译: 本文描述了用于治疗患者中病原体细胞群体的化合物,药物组合物和方法。 本文所述的化合物包括多种细胞毒性药物和维生素受体结合配体的缀合物。 多种药物可以相同或不同。 类似地,维生素受体结合配体可以相同或不同。 缀合物还包括由一个或多个间隔基连接体,杂原子接头和可释放接头形成的接头。